For Scientists

Scientific Meetings

Accelerating Cancer Cures Research Symposia

In conjunction with the Accelerating Cancer Cures initiative to speed progress against cancer, the annual Accelerating Cancer Cures Research Symposium is designed to foster communication and collaboration between cancer researchers in industry and academia. Past meetings have included participants from Eli Lilly and Company, ARIAD, Celgene, Genentech, Gilead, Merck, Novartis, Pfizer, and Takeda Pharmaceuticals International Co., in addition to academic researchers from the top universities and institutions in the nation.

Read more about the Accelerating Cancer Cures initiative.

March 8, 2019

Hosted by Lilly Oncology, New York, New York

March 28, 2018

Hosted by Genentech, Inc., South San Francisco, California

March 6, 2017

Hosted by Novartis Institutes for BioMedical Research, Cambridge, Massachusetts

March 3, 2016

Hosted by Celgene, Summit, New Jersey

March 3, 2015

Hosted by Lilly Oncology, New York, New York

March 11, 2014

Hosted by Genentech, Inc., South San Francisco, California

March 4, 2013

Hosted by Takeda Pharmaceuticals International Co., Cambridge, Massachusetts

Read about the symposium on the blog from Millennium: The Takeda Oncology Company, "Curing Cancer: We Can’t Do It Alone"

March 3, 2012

Hosted by Pfizer, New York, New York

Damon Runyon Fellows’ Retreats

To add to the training potential of Damon Runyon Fellowship Awards, the Foundation hosts annual Fellows' Retreats. These meetings allow the brightest young scientists in the country to interact with their peers, network with accomplished senior scientists and initiate valuable interdisciplinary collaborations.

Save the Date for the 2018 Fellows' Retreat.
Damon Runyon logo for posters and slides.

Sohn Conference: Pediatric Cancer in a Post-genomic World

March 30 - April 1, 2016
The New York Academy of Sciences

This 2.5-day conference will convene leading researchers, clinicians, pediatric cancer advocates, and industry and governmental stakeholders from around the globe to identify strategies for improving treatment of cancers among pediatric populations. Conference speakers will present emerging basic and clinical cutting edge research in epigenetics, mechanisms of metastasis and disease recurrence, disease risk factors, and diagnostics in pediatric oncology, as well as novel therapies and strategies to improve clinical development and treatment access.

Presented by The Sohn Conference Foundation and the New York Academy of Sciences.